Admittedly, some of that purchase price is because of AMG162; nevertheless panitumumab is probably the primary value driver given that it is closest to approval.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.